Research Studies
Do We Need Large-Scale Randomized Double Blind Clinical Trials for Medical Cannabis?
Here is a great editorial by Judith Stamps which addresses something we are hearing often today – the “lack of clinical trials” that demonstrate the effectiveness of marijuana as medicine and proposes that the large-scale trial mentality is wrong for cannabis. If you’ve been following current events on medical cannabis, you will have heard its
20 Medical Studies That Show Cannabis Can Be A Potential Cure Cancer
Cannabis has been making a lot of noise lately. Multiple states across the United States and countries around the world have successfully legalized medical Marijuana, and the Uruguay parliament recently voted to create the world’s first legal marijuana market. This is good news as the health benefits of Cannabis are vast.
Study: Cannabinoids Reduce ErbB2-driven Breast Cancer Progression
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition Abstract Background ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and reduced responsiveness to standard therapies. Although specific ErbB2-targeted therapies have been designed, only a small percentage of patients respond to these treatments and most of them eventually relapse. The
Smoked Cannabis For Chronic Neuropathic Pain: A Randomized Controlled Trial
A new randomized, double-blind study shows that a single inhalation of 25 mg of 9.4% tetrahydrocannabinol herbal cannabis three times daily for five days reduced the intensity of pain, improved sleep and was well tolerated. Abstract Background Chronic neuropathic pain affects 1%–2% of the adult population and is often refractory
Over 100 Scientific Studies Agree: Cannabis Annihilates Cancer
Considering that up until about 85 years ago, cannabis oil was used around the world to treat a variety of diseases, including cancer, it is not surprising that the phasing out of cannabis to treat illness coincided with the rise of pharmaceutical companies. Rick Simpson, a medical marijuana activist, is on
Scientists Debunk Theory That Pot Is a Gateway Drug
Data from the 2012 National Survey on Drug Use and Health showed that 60 percent of pot users go on to try other drugs, which might seem to prove the “gateway” theory, except that 88 percent of drug users started with alcohol, according to several studies reported in The Atlantic.
Study: Parents Report CBD Extracts Reduce Seizures In Children
LOS ANGELES, CA — The administration of cannabis preparations high in cannabidiol (CBD) are associated with a reduction in seizure frequency in adolescents, according to survey data published in the journal Epilepsy & Behavior. Investigators at Mattel’s Children’s Hospital at the University of California, Los Angeles surveyed 117 parents who
Cannabis Eases Chronic Pain Better Than Commonly Prescribed Opioids
Cannabis can ease chronic pain more effectively than conventional medicines, according to a new study likely to flame the debate on the medical use of marijuana. Researchers from the Australian National Drug and Alcohol centre found that patients with chronic pain who used the drug said it eased their symptoms
New Cannabis and Cannabinoid Research Journal
A new Cannabis and Cannabinoid Research Journal is on the way. It is scheduled to be launched in fall 2015. Cannabis and Cannabinoid Research, a new peer-reviewed, open access journal from Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com/), is the only journal dedicated to the scientific, medical, and psychosocial exploration of
The Science Behind Sanjay Gupta’s WEED 3
Trauma neurosurgeon turned journalist Dr. San Jay Gupta fired another broadside into cannabis prohibition Sunday with the one-hour CNN special WEED 3, on the eve of 4/20. In it, the one-time U.S. Surgeon General candidate called for a “medical marijuana revolution” and demanded the botanical be legalized for medical purposes.